Tag: Evotec

Merck Agreed to Provide Evotec Access to CRISPR Gene-Editing Technology

gene therapy
Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Evotec, an inte...

Evotec SE and Vifor Pharma Announced Launch of Joint Venture Focused on Nephrology

evotec
Evotec SE and Vifor Pharma announced the launch of a 50:50 joint venture focused on the discovery and development of novel nephrology therapeutics. Vifor Pharma will be benefiting from access to an ex...

Evotec SE Announced Academic BRIDGE Partnership with Integra Holdings and Yissum

evotec
Evotec SE announced the inauguration of LAB555, an academic BRIDGE partnership with Integra Holdings and Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem. The partnership ...

Evotec and Biocon Entered into Strategic Licensing Agreement for Biosimilar Asset

biocon
Evotec SE and Biocon Limited announced that Biocon Biologics, a wholly owned subsidiary of Biocon Ltd, and Just – Evotec Biologics, wholly owned by Evotec, have entered into a strategic licensing agre...

Evotec SE and Celmatix to Develop Pre-Clinical Programs

evotec
Evotec SE and Celmatix Inc., a precision medicine company with a proprietary multi-omics platform, announced a partnership to develop pre-clinical programmes in prevalent but underserved conditions af...

Evotec Milestone Achievement in Drug Discovery Partnership with Aeovian

evotec
Evotec SE announced that it reached a milestone in a drug discovery and development partnership with the biopharmaceutical company Aeovian Pharmaceuticals, Inc. Aeovian and Evotec entered into a dr...

Evotec Announced Strategic Drug Discovery Collaboration with Takeda

takeda
Evotec SE announced a strategic, multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Under the collaboration, the parties aim to establish at least five drug discovery ...

Evotec SE Reported Financial Results for the First Half of 2019

Evotec SE reported financial results and corporate updates for the first half of 2019. STRONG FINANCIAL PERFORMANCE Group revenues up 16% to € 207.1 m (H1 2018: € 178.9 m) Adjusted Group EBIT...

Evotec SE and Lygature to Battle Together Against Antimicrobial Resistance

Antimicrobial resistance
Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterial agents: Gram-Negative Antibacterials NOW. The new GNA NOW project, led by Evotec SE...

Nosopharm and Evotec SE Announce Partnership to Accelerate Development of Novel Antibiotics

evotec
Nosopharm, a company dedicated to the research and development of new anti-infective drugs, and Evotec SE, a drug discovery and development company, announced their partnership aimed at advancing Noso...

Evotec and Celgene Expand its Alliance

Evotec SE announced that its strategic alliance with Celgene Corporation has been expanded to include a new cell type triggering a payment of $ 9.0 m to Evotec. Evotec and Celgene initiated the col...

Evotec Announced Acquisition of Just Biotherapeutics

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc., for up to $ 90 m including potential performance-based earn-out components expecte...

Evotec and Indivumed GmbH Will Work Together to Discover the Treatment of Colorectal Cancer

Evotec and Indivumed GmbH have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer ("CRC"). The collaboration, which run...

Evotec and Galapagos to Focus on Fibrosis

Evotec AG and Galapagos NV announced a global collaboration focused on a novel target for fibrosis and other indications. The collaboration concerns a small molecule programme, currently in pre-cli...

Evotec sets up a drug discovery alliance with LEO Pharma

pharma
Evotec AG (Germany) announced a new integrated drug discovery alliance with LEO Pharma (Denmark), a global leader in medical dermatology.

Evotec starts AI-driven drug discovery collaboration with Immuneering

lab plates
Evotec AG (Germany), a drug discovery alliance and development partnership company, announced that it has entered into a research collaboration with Immuneering Corporation (USA).